Summary
Overview
The PNG Australia Transition to Health (PATH) is a 6-year (2020-2026) health sector program funded by the Australian Government under the Papua New Guinea – Australia Partnership for Development. PATH works with the PNG Government to improve coverage and quality of health services for the people of PNG through effective, equitable, efficient, and inclusive interventions.
PATH provides operational support to AIHSS2, a 4-year program (2024–2027) funded by the Governments of Australia and New Zealand and Gavi, the Vaccine Alliance.
AIHSS2 End of Program Outcomes (EOPOs) aim to increase capacity of PHAs/BDoH and improve delivery of essential health services and include:
-
PHAs/BDoH increase vaccination coverage through integrated service delivery in selected provinces and decrease the number of children receiving no vaccines.
-
PHAs/BDoH planning and public financial management (PFM) capabilities and practices are strengthened.
-
PHAs/BDoH embed gender equality, disability and social inclusion principles in routine immunisation to increase equity and reach of routine immunisation in service delivery. direction.
Description
Brief
The purpose of the evaluation is to assess the progress of the program against the EOPOs and to provide recommendations to the Senior Management Group (SMG) on the remaining program period and possible future investments. In particular, the evaluation will assess the programme in terms of effectiveness, efficiency, sustainability, coherence and partnerships. The evaluation process will also identify and emphasise key lessons learned to inform future program investments. The evaluation will integrate GEDSI as crosscutting themes throughout its deliverables and process.
The evaluation has 5 KEQs that need to be addressed and include:
- KEQ 1 Effectiveness (service delivery and equity): To what extent have PHAs/BDoH been effective in increasing vaccination services, integrating health services and improving vaccination coverage in selected provinces/ARoB, including in effectively reaching disadvantaged and vulnerable groups through routine immunisation?
- KEQ 2 Effectiveness (systems & PFM): To what extent have PHA/BDoH PFM capabilities effectively managed and implemented AIHSS2 grants (refers to PHA direct recipients only), or worked towards doing so through strengthened PFM capabilities (refers to all other PHAs)?
- KEQ 3 Efficiency: To what extent has AIHSS2 been managed and implemented efficiently to achieve its intended outcomes, including through leveraging the support and networks of other programs or organisations?
- KEQ 4 Sustainability: To what extent will AIHSS2 promote long term PFM and routine immunisation capacity that leads to sustained benefits and scalable impacts?
- KEQ 5 Coherence and partnerships: To what extent are donors (DFAT, MFAT, Gavi) recognised as best practice partners committed to working collaboratively with the Government of PNG and other donors on PNG's priority areas?
- Cross-cutting requirement: All KEQs should integrate GEDSI considerations, including differential access, participation and outcomes for women, people with disabilities and other vulnerable groups and the extent to which GEDSI interventions have achieved positive outcomes.
A detailed Request For Quotation documentation can be requested by emailing png.tenders@amspng.org or accessed online at https://www.abtglobal.com/doing-business-with-abt/solicitations. All enquiries should be made to png.tenders@amspng.org.
The closing date and time for submissions is 5:00 pm (Port Moresby Time), Friday, 3 July 2026.
Documents (provided upon request or accessed online)
- PATH-2026-RFQ-11- AIHSS2 Short-Term MERLA Team- FINAL
